In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they plan to reclassify cannabis like a Agenda III drug. This rescheduling will figure out that cannabis has legitimate health care purposes and will help open the doorway to analysis on other possible treatment uses. Huge